XML 62 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Nature of Business - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Nov. 03, 2020
Nov. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Nov. 30, 2021
Nature of Business [Line Items]            
Net proceeds from initial public offering ("IPO")         $ 317,605  
Cash and cash equivalents     $ 188,460 $ 764,375 $ 850,117  
Cash and cash equivalents and marketable securities     $ 646,709      
Number of shares issued     83,287,639 83,102,730    
Common Stock            
Nature of Business [Line Items]            
Shares issued         14,375,000  
IPO | Common Stock            
Nature of Business [Line Items]            
Shares issued 14,375,000          
Share price $ 24.00          
Net proceeds from initial public offering ("IPO") $ 317,605          
IPO | Series A, B, C, D and D-1 Convertible Preferred Stock | Common Stock            
Nature of Business [Line Items]            
Convertible preferred stock converted into shares 57,932,090          
Roche License Agreement            
Nature of Business [Line Items]            
Non-refundable upfront payment received   $ 350,000        
Received pursuant of milestone       $ 50,000    
Jeffries | Sales Agreement            
Nature of Business [Line Items]            
Commission percentage of aggregate gross proceeds from each sale of shares     3.00%      
Number of shares issued     0      
Jeffries | Maximum | Sales Agreement            
Nature of Business [Line Items]            
Aggregate offering price           $ 200,000